B
BioRestorative Therapies Inc (BRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$1.34
-0.08 (-5.63%)
Market Cap: $1.96M
Last updated: Nov 17, 2026 at 4:10 PM ET
BioRestorative Therapies Inc (BRTX) Valuation Multiples
BioRestorative Therapies (BRTX) trades at 66.4x sales and 7.9x book value. Its P/B of 7.9x is below its 5-year median of 23.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 66.4x |
| Price to book | 7.9x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 7.9x | 23.7x | N/A |
Valuation History
Over the 5 of the 10 year ends shown that have a P/S, its P/S ranged from 100.6x in 2021 to 971.1x in 2023.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $23.50 | 570.5x | 584.7x |
| 2024 | $28.60 | 565.7x | 26.0x |
| 2023 | $34.80 | 971.1x | 16.4x |
| 2022 | $55.00 | N/A | 19.6x |
| 2021 | $86.80 | 100.6x | N/A |
| 2020 | $460.00 | 109.4x | N/A |
| 2019 | $333.33 | N/A | N/A |
| 2018 | $60,000.00 | N/A | N/A |
| 2017 | $246,666.67 | N/A | N/A |
| 2016 | $220,000.00 | N/A | N/A |
Frequently Asked Questions About BRTX
What is BRTX's price to sales ratio?
BioRestorative Therapies has a price to sales ratio of 66.4x.
BRTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors